Equities

Zhong Yuan Bio-Technology Holdings Ltd

ZHYBF:PKC

Zhong Yuan Bio-Technology Holdings Ltd

Actions
  • Price (USD)4.99
  • Today's Change0.00 / 0.00%
  • Shares traded99.00
  • 1 Year change+6.62%
  • Beta--
Data delayed at least 15 minutes, as of Oct 15 2024 17:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Income statement information is not available for Zhong Yuan Bio-Technology Holdings Ltd.
Gross margin106.30%
Net profit margin7.57%
Operating margin9.14%
Return on assets6.49%
Return on equity64.23%
Return on investment19.10%
More ▼

Cash flow in USDView more

In 2024, cash reserves at Zhong Yuan Bio-Technology Holdings Ltd fell by 132.58k. Cash Flow from Financing totalled 715.09k or 16.66% of revenues. In addition the company used 745.82k for operations while cash from investing was breakeven.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.0143
Tangible book value per share0.0143
More ▼

Balance sheet in USDView more

Zhong Yuan Bio-Technology Holdings Ltd has a Debt to Total Capital ratio of 85.93%.
Current ratio0.8678
Quick ratio0.8309
Total debt/total equity6.02
Total debt/total capital0.8593
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.